Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Shai White-Gilbertson, PhD, MSCR, Dipl Ac, CTR
Dr. White-Gilbertson began her professional life as an acupuncturist in 2000 after studying at The Midwest College for Oriental Medicine (then The Midwest College for the Study of Oriental Medicine). In 2002, a long standing interest in possible connections between acupuncture and Western biomedicine led her to formally train in molecular biology. She earned a PhD for her work in chemotherapy resistance and programmed cell death as part of a dual degree program which also granted her a Masters in Clinical Research from the Medical University of South Carolina in 2009. In total, Dr. White-Gilbertson spent 10 years researching cancer biology and now works with cancer databases addressing issues of incidence and outcome for this difficult disease. She lives and works in Charleston, SC.